Cadrenal Therapeutics (CVKD) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CVKD Cadrenal Therapeutics

Watchlist

11.200
-0.400-3.45%

Close Dec 13 16:00 ET

11.250
+0.050+0.45%

Post 20:01 ET

18.58MMarket Cap-1.82P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga16:06 ET
Cadrenal Therapeutics Named Anticoagulation Therapy Company of the Year by Pharma Tech Outlook
PR NewswireNov 19 09:00 ET
Cadrenal Therapeutics Files to Sell 590K Shares of Common Stock for Holders
TipRanksNov 14 16:11 ET
CADRENAL THERAPEUTICS HIGHLIGHTS PRESENTATION AT EUROPEAN ASSOCIATION FOR CARDIO-THORACIC SURGERY (EACTS) MEDICAL CONGRESS
Yahoo FinanceNov 12 09:00 ET
Cadrenal Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Dow JonesNov 11 13:06 ET · Ratings
H.C. Wainwright Maintains Cadrenal Therapeutics(CVKD.US) With Buy Rating, Cuts Target Price to $32
Moomoo NewsNov 8 10:31 ET · Ratings

Comments

Stock_Drift

Sep 23 15:48

$Cadrenal Therapeutics (CVKD.US)$

Stock_Drift

Sep 17 17:23

$Cadrenal Therapeutics (CVKD.US)$

Stock_Drift

Sep 13 14:27

$Cadrenal Therapeutics (CVKD.US)$

Jaguar8

Aug 20 08:42

NEWS

$Cadrenal Therapeutics (CVKD.US)$
Published Findings Highlight Tecarfarin's Potential and Reinforce Need for Better Anticoagulation Therapy in LVAD Patients
Cadrenal Therapeutics (Nasdaq: CVKD) highlighted a recently published manuscript in the Journal of Cardiac Failure, evaluating the relationship between time in therapeutic range (TTR) management quality and clinical outcomes for left ventricular assist device (LVAD) patients. The findings emphasize the need for improved anticoagulation th...

frogoracletrading

Aug 9 17:53

$CVKD Support / Resistance Levels

Needs a clean break of .52 for any move upwards. Here are the levels to watch.
Larger Image: tradingview.com...
$Cadrenal Therapeutics (CVKD.US)$

Heat List

Overall

No Data